Fujicopian Co., Ltd. (7957.T)
JPY 1575.0
(0.0%)
JPY 1575.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -46.67 Million | 706.53 Million | 898.64 Million | 794.82 Million | 680 Million |
| Net Income | -772.2 Million | 649.85 Million | 414.58 Million | -126.3 Million | 314 Million |
| Depreciation & Amortization | 637.08 Million | 549.1 Million | 544.86 Million | 509.29 Million | 472 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 218.05 Million | -475.89 Million | -111.36 Million | 403.23 Million | 233 Million |
| Other non-cash items | -18.09 Million | 61.97 Million | 9.9 Million | 6.79 Million | -339 Million |
| Investing Cash Flow | -778.7 Million | -988.15 Million | -728.27 Million | -673.57 Million | -799 Million |
| Investments in PPE | -834.2 Million | -987.28 Million | -690.3 Million | -660.88 Million | -755 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -8.01 Million | -7.72 Million | -7.33 Million | -6.92 Million | -34.47 Million |
| Sales/Maturities of investments | 68.06 Million | - | - | - | 1.42 Million |
| Other Investing Activities | -4.54 Million | 6.85 Million | -34.3 Million | -5.56 Million | -44 Million |
| Financing Cash Flow | -267.46 Million | 40.96 Million | -451.1 Million | -309.69 Million | -814 Million |
| Debt repayment | -245.35 Million | -152.84 Million | -375.19 Million | -113.1 Million | -624 Million |
| Dividends payments | -148 Million | -99.61 Million | -61.43 Million | -95.02 Million | -114.36 Million |
| Common Stock Repurchased | -89 Thousand | -131 Thousand | -386 Thousand | -229 Thousand | -302 Thousand |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -2000.00 | -2000.00 | 30 Million | -2000.00 | -1000.00 |
| Accounts receivables | 373 Million | -166 Million | -301 Million | 551 Million | 327 Million |
| Accounts payables | -509.55 Million | 257.81 Million | 222.5 Million | -234.03 Million | -232.21 Million |
| Inventory | 332.61 Million | -457.89 Million | -30.61 Million | 64.25 Million | -86 Million |
| Other working capital | 43 Million | -21 Million | 29 Million | 46 Million | -8 Million |
| Cash at beginning of period | 4.27 Billion | 4.32 Billion | 4.57 Billion | 4.76 Billion | 5.71 Billion |
| Cash at end of period | 3.23 Billion | 4.27 Billion | 4.32 Billion | 4.57 Billion | -946 Million |
| Capital Expenditure | -834.2 Million | -987.28 Million | -690.3 Million | -660.88 Million | -755 Million |
| Effect of forex changes on cash | 56.04 Million | 186.29 Million | 28.13 Million | -2.17 Million | -13 Million |
| Net cash flow / Change in cash | -1.03 Billion | -54.36 Million | -252.6 Million | -190.61 Million | -6.66 Billion |
| Free Cash Flow | -880.87 Million | -280.75 Million | 208.34 Million | 133.94 Million | -75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 17 Million | -231 Million | -326 Million | -772.2 Million | -288 Million | -89 Million |
| Depreciation & Amortization | - | - | - | 637.08 Million | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 218.05 Million | - | - |
| Other non-cash items | -17 Million | 231 Million | 326 Million | -18.09 Million | 288 Million | 89 Million |
| Investing Cash Flow | - | - | - | -778.7 Million | - | - |
| Investments in PPE | - | - | - | -834.2 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -8.01 Million | - | - |
| Sales/Maturities of investments | - | - | - | 68.06 Million | - | - |
| Other Investing Activities | - | - | - | -4.54 Million | - | - |
| Financing Cash Flow | - | - | - | -267.46 Million | - | - |
| Debt repayment | - | - | - | -245.35 Million | - | - |
| Dividends payments | - | - | - | -148.34 Million | - | - |
| Common Stock Repurchased | - | - | - | -89 Thousand | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -2000.00 | - | - |
| Accounts receivables | - | - | - | 373 Million | - | - |
| Accounts payables | - | - | - | -509.55 Million | - | - |
| Inventory | - | - | - | 332.61 Million | - | - |
| Other working capital | - | - | - | 43 Million | - | - |
| Cash at beginning of period | - | - | - | 4.27 Billion | - | - |
| Cash at end of period | - | - | - | 3.23 Billion | - | - |
| Capital Expenditure | - | - | - | -834.2 Million | - | - |
| Effect of forex changes on cash | - | - | - | 56.04 Million | - | - |
| Net cash flow / Change in cash | - | - | - | -1.03 Billion | - | - |
| Free Cash Flow | - | - | - | -880.87 Million | - | - |
1332
8616
JEXYF
002154
6227
DFILF